|
EP2345415A1
|
|
Therapeutic/prophylactic agent for prostate cancer
|
|
JP2011050292A
|
|
Development of highly functionalized hvj-e
|
|
WO2008096816A1
|
|
Angiogenesis inducer and polypeptide for use in the angiogenesis inducer
|
|
WO2008096814A1
|
|
Novel polypeptide and antibacterial agent comprising the same as active ingredient
|
|
JP2008308440A
|
|
Pharmaceutical delivery vehicle for cancer treatment, method for producing the same, and preparation using the same
|
|
JP2008212023A
|
|
Method for protein introduction by hvj envelope
|
|
EP1978096A1
|
|
Novel oligonucleotide and nf-kappa b decoy comprising the same
|
|
EP1947181A1
|
|
Mutant paramyxovirus and method for production thereof
|
|
US2008318299A1
|
|
Methods for the production of hemagglutinating virus of Japan and adenovirus using cultured cells
|
|
WO2007013641A1
|
|
Detection method for use in diagnosis of polymorphism located in cmya5 gene and disease
|
|
WO2006011580A1
|
|
Method of purifying virus envelope
|
|
US2008226674A1
|
|
Composition having antitumor effect
|
|
WO2005095613A1
|
|
Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF
|
|
WO2005095621A1
|
|
Method of regulating gene introduction with use of artificial magnetic material and system therefor
|
|
WO2005090574A1
|
|
Vascular endothelial growth inhibiting gene
|
|
EP1726647A1
|
|
Gene promoting vascular endothelial cell growth
|
|
WO2005090585A1
|
|
Solid phase gene transfer method using virus vector, composition for the method and apparatus for the method
|
|
WO2005090549A1
|
|
Cell culture microwell
|
|
WO2005083062A1
|
|
Cell vaccine
|
|
EP1566436A1
|
|
A method for isolating a nucleic acid having an intended functional property anda kit therefor
|
